China’s Rude Awakening - Review of Our Best and Worst Calls in 2018+Top Trade Ideas Q1 2019
Our calls had great successes this year starting off calling out a fraudulent US holding company boasting of “world class” AI development in...
846 Views
Usana Health Sciences: 3Q EPS Upside & FY Outlook Raised; Underlying Momentum Continues to Build
Usana Health Sciences (USNA US) reported 3Q EPS of $1.24, ahead of our $1.15 estimate and consensus of $1.12 on better than expected organic sales...
405 Views
Usana Health Sciences: This Week’s Earnings 2-Minute Drill
We recommend Usana Health Sciences (USNA US) as one of our top growth picks and believe the company has built up considerable momentum as the year...
322 Views
Usana Health Sciences (USNA): Highlights from Recent Investor Meetings; Tone Remains Upbeat
We hosted meeting with investors for Usana Health Sciences (USNA US) CFO Doug Hekking and EVP Legal Josh Foukas in Boston back in September. The...
402 Views
Sector Analysis: Direct Selling: Stocks Are Sharply Outperforming Broader Averages This Year
Investment Summary Our proprietary Lane Research Direct Selling index outpaced the S&P 500 by a factor of 4x through the first 3 quarters of...
325 Views